| Filed On | Filing |
|---|---|
| 26 Oct 2026 |
Form 4/A: Langer Dennis, Director · Quoin Pharmaceuticals Ltd
Holds 49,687 shares of ADSs |
| 28 Aug 2026 |
Form 4: Langer Dennis, Director · Quoin Pharmaceuticals Ltd
Received 34,534 shares as a grant or award ($178K) |
| 06 Feb 2026 |
Form 4: Langer Dennis, Director · Quoin Pharmaceuticals Ltd
Granted 21,709 Share Option (Right to Buy) |
| 15 Oct 2025 |
Form 4: Langer Dennis, Director · Quoin Pharmaceuticals Ltd
Bought 15,152 shares ($129K) · Acquired 15,152 Series H Warrants (Right to Buy) (Open Market Purchase) · Acquired 15,152 Series I Warrants (Right to Buy) (Open Market Purchase) · 2 more |
| 25 Aug 2025 |
Form 4: Langer Dennis, Director · Quoin Pharmaceuticals Ltd
Granted 13,682 Share Option (Right to Buy) |
| 02 Jun 2025 |
Form 4: Langer Dennis, Director · Quoin Pharmaceuticals Ltd
Granted 7,760 Share Option (Right to Buy) |
| 10 Dec 2024 |
Form 4: Langer Dennis, Director · Quoin Pharmaceuticals Ltd
Granted 50,714 Share Option (Right to Buy) |
| 10 Jun 2024 |
Form 4: Langer Dennis, Director · Quoin Pharmaceuticals Ltd
Sold 297 shares ($217) |
| 07 Jun 2024 | 144 |
| 30 Oct 2023 |
Form 4: Langer Dennis, Director · Quoin Pharmaceuticals Ltd
Granted 7,652 Share Option (Right to Buy) |
| 07 Mar 2023 | Form 3/A: Langer Dennis, Director · Quoin Pharmaceuticals Ltd |
| 03 Jan 2023 |
Form 3: Langer Dennis, Director · Quoin Pharmaceuticals Ltd
Holds 21,005,000 shares of Ordinary Shares |
| 30 Jun 2022 |
Form 4: Langer Dennis, Director · Myriad Genetics Inc
Holds 106,802 shares of Common Stock |
| 03 Jun 2022 |
Form 4: Langer Dennis, Director · Myriad Genetics Inc
Received 17,275 shares as a grant or award |
| 10 Dec 2021 |
Form 4: Langer Dennis, Director · Ernexa Therapeutics Inc
Granted 67,000 Stock Option |
| 05 Aug 2021 |
Form 4: Langer Dennis, Director · Myriad Genetics Inc
Received 30,000 shares by exercise or conversion ($762K) · Sold 30,000 shares ($1.04M) |
| 04 Jun 2021 |
Form 4: Langer Dennis, Director · Myriad Genetics Inc
Received 12,848 shares as a grant or award |
| 05 May 2021 |
Form 3: Langer Dennis, Director · Ernexa Therapeutics Inc
No securities owned |
| 07 Dec 2020 |
Form 4: Langer Dennis, Director · Myriad Genetics Inc
Received 15,889 shares as a grant or award |
| 06 Dec 2019 |
Form 4: Langer Dennis, Director · Myriad Genetics Inc
Received 11,687 shares as a grant or award |
Loading...